Charles M. Farkas's Insider Trades & SAST Disclosures
Charles M. Farkas's most recent trade in Conmed Corp. was a trade of 1,000 Common Stock done at an average price of $39.6 . Disclosure was reported to the exchange on Sept. 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Charles M. Farkas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp. | Farkas M. Charles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.64 per share. | 05 Sep 2024 | 1,000 | 20,880 (0%) | 0% | 39.6 | 39,640 | Common Stock |
| Conmed Corp. | Charles Farkas M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 1,000 | 0 | - | - | SARs (Stock Appreciation Rights) | |
| Conmed Corp. | Charles M. Farkas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.31 per share. | 05 Sep 2024 | 534 | 20,346 (0%) | 0% | 74.3 | 39,682 | Common Stock |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,503 | 5,503 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 479 | 479 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 302 | 19,880 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 302 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,826 | 2,826 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 335 | 19,578 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 335 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 302 | 302 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,453 | 3,453 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 19,243 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 335 | 335 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 18,431 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 865 | 865 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 812 | 812 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 1,843 | 1,843 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Charles M. Farkas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 1,521 | 1,521 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 1,407 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Charles M. Farkas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 1,407 | 16,910 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges